Disclaimer for the US market

The products and information provided on this website are intended for healthcare professionals. These products are not for sale or distribution in the United States and statements made regarding these products have not been evaluated by the U.S. Food and Drug Administration (FDA). The efficacy of these products has not been confirmed by FDA-approved research and these products are therefore not intended to diagnose, treat, cure or prevent any disease. All information presented here is for general information purposes only and not meant as a substitute for or alternative to advice from healthcare practitioners. The Federal Food, Drug and Cosmetic Act requires this notice.

Neither the Company nor its representatives is providing any medical advice, and none should be inferred, from any ideas, suggestions, testimonials or other information set forth on this website or in other Company materials or provided over the phone, in the mail, in product packaging, or in email correspondence. This website may contain links to third-party websites. The Company provides these links as a convenience only and does not endorse any of these sites. The Company is not responsible for the content of, and does not make any representations regarding the materials on, such linked third-party websites. If you decide to access or rely on information at linked third-party website, you do so at our own risk. Our terms and conditions, including disclaimers, are more fully set forth in our Terms of Use, Privacy Policy and Terms of Online Sales.

„Freiburg model” for Life Saving of Resuscitation Patients

Florian Wahl, Chairman of the Committee for Social Affairs, Health and Integration in the State Parliament of Baden-Württemberg (BW), together with an SPD delegation from Freiburg and BW, visited the University Emergency Center of the Medical Center – University of Freiburg and the CARL Academy in the Güterhalle.

They were not only introduced to the Freiburg Model Project for Life Saving in a joint presentation and a realistic simulation but were also actively and successfully involved in the simulation of a rescue operation. The groundbreaking idea of the model projects is to structure and structure and systematize the rescue chain as a whole for patients with cardiac arrest.

Simulation of a rescue operation

Prof. Michael Müller, chief physician at St. Josef’s Hospital in Freiburg and co-initiator of the “Region der Lebensretter” (Region of Life Savers) association, presented the successes to date of a structured, digitally via an app supported, system for first responder alerting. After all, it is the first few minutes that determine the chance of survival for resuscitation patients.

If the initial care is successful, a specialized Cardiac Arrest rescue team can take over for a targeted reperfusion strategy on the scene. For the clinical team of the Medical Center – University of Freiburg, Prof. Georg Trummer and Prof. Jörg Busch presented the structures of the Freiburg model, including the REA-MOBIL, which is specifically equipped for the out-of-hospital use for the care for resuscitation patients. For targeted reperfusion after cardiac arrest, the researchers at the Medical Center – University of Freiburg have developed CARL, a dedicated care concept from which patients in Freiburg are already benefiting today.

“The Freiburg model demonstrates very well the potential that can be unleashed for improved patient care when clinical research, intersectoral care management and (digital) cutting-edge technology are systematically linked,” summarizes Dr. Thomas Kraft, CEO of Resuscitec. “We are convinced that the Freiburg model will find increasingly application beyond Baden-Württemberg.”

Pressekontakt

Resuscitec GmbH
Engesserstraße 4a
D-79108 Freiburg
press@resuscitec.de

Disclaimer

Sie erhalten das Presseclipping der Resuscitec GmbH aufgrund Ihrer Beziehung zu unserem Unternehmen. Wir verarbeiten Ihre Daten auf Grundlage unseres berechtigten Interesses zum Zweck der persönlichen Ansprache und zum Versand unseres Presseclippings. Verantwortlich für die Datenverarbeitung ist die Resuscitec GmbH. Weitere Informationen zum Datenschutz finden Sie in unseren Datenschutzhinweisen. Sie können der Verarbeitung Ihrer personenbezogenen Daten für den Versand des Presseclippings jederzeit formlos widersprechen.

Nutzungshinweis

Aus urheberrechtlichen Gründen dürfen die Artikel weder in digitaler noch ausgedruckter Form an Dritte weitergegeben werden. Sie sind nur zum persönlichen Gebrauch bestimmt, der Aufbau einer Datenbank mit digitalisierten Artikeln ist nicht erlaubt.